HPNE introduces defined tubing routing for single-use facilities
Flexible support system simplifies and secures tubing paths for biopharmaceutical manufacturers.
High Purity New England (HPNE), a supplier of biopharma equipment and process systems has launched its new line of defined tubing routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing.
This modular system holds silicon tubing securely, eliminating dips and preventing dips that occur in unsupported pressurized lines.
For the first time, skid builders, process engineers, and facilities managers have a proven, mass-produced, and versatile option specifically engineered to define supported and clean routing of single-use tubing.
DTR simplifies single-use tubing management in a cleanroom environment, with colour-coded rigid supports for easy visual identification of each tube connection.
With solid and supported bridges, even over short spans, it securely holds any length of single-use tubing.
The combination of clips and routes are mounted to brackets to provide rigid and secure support, even over long tube runs.
Portable mounting panels can be engineered to get tubing off the floor without damaging cleanroom walls.
Megan Baillie, Product Specialist at HPNE, described DTR as a “simple solution to a ubiquitous problem". She added: “Skid builders will love the versatility of this product as it can be modified for different needs, including attaching to walls, chromatography columns, and exfiltration systems.”
DTR comes in 2.9-m length, fits a wide range of clips and standard tubing sizes (6 mm–19 mm) and comes in many colours.
As the US facility installer, HPNE can customize DTR for a variety of applications, including for new builds and retrofitted into existing single-use facilities; improved aesthetic to ensure a process appears organized and secure for virtual inspections; and reduced human error and trip hazards.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...